Milestone Pharmaceuticals (MIST) Enterprise Value (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Enterprise Value of -$184.2 million for Q1 2026, down 73.86% on a QoQ basis from -$106.0 million in Q4 2025, and down 1594.26% year-over-year from $12.3 million in Q1 2025.
Milestone Pharmaceuticals (MIST) Enterprise Value (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Enterprise Value history runs 9 years deep, the most recent figure standing at -$184.2 million for Q1 2026.
- Quarterly Enterprise Value fell 1594.26% year-over-year to -$184.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$184.2 million (down 1594.26% YoY) and the FY2025 annual result came in at -$106.0 million, down 51.99% from the prior year.
- Enterprise Value was -$184.2 million for Q1 2026 at Milestone Pharmaceuticals, down from -$106.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.9 million in Q1 2025 and bottomed at -$184.2 million in Q1 2026.
- A 5-year average of -$88.5 million and a median of -$79.4 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value soared 86.3% — and 2026, when it tumbled 1594.26%.
- Milestone Pharmaceuticals' Enterprise Value stood at -$64.5 million in 2022, then retreated by 2.21% to -$66.0 million in 2023, then declined by 5.69% to -$69.7 million in 2024, then sank by 51.99% to -$106.0 million in 2025, then tumbled by 73.86% to -$184.2 million in 2026.
- Business Quant data shows MIST's Enterprise Value at -$184.2 million in Q1 2026, -$106.0 million in Q4 2025, and -$118.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | -184.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -184.22 Mn |
| Dec 31, 2025 | -105.96 Mn |
| Sep 30, 2025 | -118.50 Mn |
| Jun 30, 2025 | -43.42 Mn |
| Mar 31, 2025 | -10.87 Mn |
| Dec 31, 2024 | -69.71 Mn |
| Sep 30, 2024 | -63.62 Mn |
| Jun 30, 2024 | -69.99 Mn |
| Mar 31, 2024 | -79.35 Mn |
| Dec 31, 2023 | -65.96 Mn |
| Sep 30, 2023 | -141.57 Mn |
| Jun 30, 2023 | -87.59 Mn |
| Mar 31, 2023 | -128.00 Mn |
| Dec 31, 2022 | -64.54 Mn |
| Sep 30, 2022 | -77.23 Mn |
| Jun 30, 2022 | -86.24 Mn |
| Mar 31, 2022 | -108.20 Mn |
| Dec 31, 2021 | -114.14 Mn |
| Sep 30, 2021 | -141.40 Mn |
| Jun 30, 2021 | -173.80 Mn |